- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 253/10 - Condensed 1,2,4-triazinesHydrogenated condensed 1,2,4-triazines
Patent holdings for IPC class C07D 253/10
Total number of patents in this class: 31
10-year publication summary
3
|
3
|
0
|
2
|
0
|
2
|
2
|
2
|
1
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Bayer HealthCare LLC | 1359 |
2 |
Takeda Pharmaceutical Company Limited | 2714 |
2 |
Japan Tobacco Inc. | 3594 |
2 |
Symrise AG | 1722 |
2 |
Bristol-myers Squibb Company | 4878 |
1 |
LG Display Co., Ltd. | 13438 |
1 |
The Regents of the University of California | 19898 |
1 |
Merck Sharp & Dohme Corp. | 2197 |
1 |
Dow Global Technologies LLC | 10352 |
1 |
Abbvie Inc. | 1802 |
1 |
OSRAM Opto Semiconductors GmbH | 3312 |
1 |
Alios BioPharma, Inc. | 66 |
1 |
BioCryst Pharmaceuticals, Inc. | 176 |
1 |
Incyte Corporation | 1020 |
1 |
SRI International | 1013 |
1 |
Stichting Maastricht Radiation Oncology "maastro-clinic" | 17 |
1 |
Trustees of Dartmouth College | 1086 |
1 |
Universite de Montpellier | 986 |
1 |
University of Greenwich | 71 |
1 |
Istanbul Medipol Universitesi | 177 |
1 |
Other owners | 7 |